Application of REVEAL Lite 2 and COMPERA 2.0 risk scores to patients with pulmonary arterial hypertension switching to riociguat in the REPLACE study

Autor: Benza, Raymond L., Simonneau, Gérald, Ghofrani, Hossein-Ardeschir, Corris, Paul A., Langleben, David, Rosenkranz, Stephan, White, R. James, Cheng, Chin-Chang, Campos, Frederico T.A. Figueiredo, Kim, Hyung-Kwan, Souza, Rogerio, Chang, Mikyung, Rahner, Claudia, Meier, Christian, Hoeper, Marius M.
Zdroj: In Journal of Heart and Lung Transplantation October 2024 43(10):1756-1760
Databáze: ScienceDirect